Download presentation
Presentation is loading. Please wait.
1
Volume 165, Issue 5, Pages 1481-1487 (May 2001)
BILHARZIAL RELATED, ORGAN CONFINED, MUSCLE INVASIVE BLADDER CANCER: PROGNOSTIC VALUE OF APOPTOSIS MARKERS, PROLIFERATION MARKERS, p53, E-CADHERIN, EPIDERMAL GROWTH FACTOR RECEPTOR AND c- erbB-2 ANDREA HAITEL, BERND POSCH, MAHMOUD EL-BAZ, ALAA A. MOKHTAR, MARTIN SUSANI, MOHAMED A. GHONEIM, MICHAEL MARBERGER The Journal of Urology Volume 165, Issue 5, Pages (May 2001) DOI: /S (05)66332-X Copyright © 2001 American Urological Association, Inc. Terms and Conditions
2
Fig. 1 Kaplan-Meier disease-free survival curves for transitional cell carcinoma (TCC) versus squamous cell carcinoma (SCC) (log-rank test p = ). The Journal of Urology , DOI: ( /S (05)66332-X) Copyright © 2001 American Urological Association, Inc. Terms and Conditions
3
Fig. 2 Kaplan-Meier disease-free survival curves for Bak negative versus Bak positive in squamous cell carcinoma (log-rank test p = 0.039). The Journal of Urology , DOI: ( /S (05)66332-X) Copyright © 2001 American Urological Association, Inc. Terms and Conditions
4
Fig. 3 Kaplan-Meier disease-free survival curves for Bak negative versus Bak positive in transitional cell carcinoma (log-rank test p = 0.040). The Journal of Urology , DOI: ( /S (05)66332-X) Copyright © 2001 American Urological Association, Inc. Terms and Conditions
5
Fig. 4 Kaplan-Meier disease-free survival curves for p53 40% or less versus p53 greater than 40% in squamous cell carcinoma (log-rank test p = ). The Journal of Urology , DOI: ( /S (05)66332-X) Copyright © 2001 American Urological Association, Inc. Terms and Conditions
6
Fig. 5 Kaplan-Meier disease-free survival curves for p53 40% or less versus p53 greater than 40% in transitional cell carcinoma (log rank test p = ). The Journal of Urology , DOI: ( /S (05)66332-X) Copyright © 2001 American Urological Association, Inc. Terms and Conditions
7
Fig. 6 Kaplan-Meier disease-free survival curves for p53 40% or less versus p53 greater than 40% in squamous cell carcinoma (log rank test p = ). The Journal of Urology , DOI: ( /S (05)66332-X) Copyright © 2001 American Urological Association, Inc. Terms and Conditions
8
Fig. 7 Kaplan-Meier disease free-survival curves. A, grades 1 and 2 versus 3 in squamous cell carcinoma (log rank test p = 0.021). B, c-erbB-2 negative versus c-erbB-2 positive in transitional cell carcinoma (log rank test p = 0.036). C, Bcl-x negative versus Bcl-x positive in transitional cell carcinoma (log rank test p = 0.015). D, MIB-1 30% or less versus MIB-1 greater than 30% in transitional cell carcinoma (log rank test p = 0.034). The Journal of Urology , DOI: ( /S (05)66332-X) Copyright © 2001 American Urological Association, Inc. Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.